

The Administration opposes the Gorton substitute to H.R. 956 (text of S. 565 as reported by the Senate Committee on Commerce, Science, and Transportation), because of two objectionable provisions. These provisions, which are described below, should be deleted from the Gorton substitute:

The Administration would strongly oppose these provisions in any legislation, including medical malpractice legislation.

The Administration, however, would support the enactment of limited, but meaningful, product liability reform at the Federal level. Any legislation must fairly balance the interests of consumers with those of manufacturers and sellers and should respect the important role of the States in our federal system.